NCT06394284View on ClinicalTrials.gov

Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 18, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
PTSD, Post Traumatic Stress DisorderMoral Injury
Interventions
DRUG

MDMA-AT

As described above in arm description

BEHAVIORAL

SEA-IT

As described in arm description

Trial Locations (1)

3090844

RECRUITING

METIV Israel Psychotrauma Center, Herzog Medical Center, Jerusalem

All Listed Sponsors
collaborator

Metiv Israel Psychotrauma Center

OTHER

lead

Herzog Hospital

OTHER